Home › Burkitt Lymphoma › Arizona › Tucson
Burkitt Lymphoma clinical trials in Tucson, AZ
3 studies for Burkitt Lymphoma are looking for participants at sites in and around Tucson (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Banner University Medical Center - Tucson, Tucson
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Banner University Medical Center - Tucson, Tucson
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RecruitingPhase 3
- Banner University Medical Center - Tucson, Tucson
Burkitt Lymphoma trials in other cities
- Houston, TX21 studies
- Milwaukee, WI16 studies
- Philadelphia, PA16 studies
- New York City, NY14 studies
- Chicago, IL13 studies
- Seattle, WA12 studies
- Cincinnati, OH12 studies
- Atlanta, GA11 studies
- Boston, MA10 studies
- Los Angeles, CA10 studies
- Durham, NC10 studies
- Kansas City, MO10 studies
Other studies in Tucson
- Breast Cancer20 studies
- Non-Small Cell Lung Cancer17 studies
- Obesity17 studies
- Overweight15 studies
- Metastatic Cancer14 studies
- Cancer (all types)13 studies
- Cardiovascular Disease12 studies
- Colorectal Cancer11 studies
- Prostate Cancer11 studies
- Steatotic Liver Disease10 studies
- Type 2 Diabetes10 studies
- High Blood Pressure10 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.